|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
38.21 Million
|
|
Market
Size (2030)
|
USD
47.21 Million
|
|
CAGR
(2025-2030)
|
3.59%
|
|
Fastest
Growing Segment
|
Pre-Erythrocytic
|
|
Largest
Market
|
East
India
|
Market Overview
India
Malaria Vaccine Market was valued at USD 38.21 million in 2024 and is expected
to reach USD 47.21 million by 2030 with a CAGR of 3.59% during the forecast
period. The Rising awareness among people for early detection and treatments
coupled with the rising number of people suffering from malaria are expected to
augment the growth of the India malaria vaccine market. Malaria is caused by a
parasite called Plasmodium, which is transmitted to humans through the bites of
infected mosquitoes. Malaria is preventable and treatable, but the development
of effective vaccines is essential to control and ultimately eliminate this
disease. Growing incidences of malaria in the country is a major factor, which
is surging the demand for effective malaria vaccines. These malaria vaccines
are vaccines that are designed to prevent or reduce the severity of malaria, a
disease caused by parasites that are transmitted to humans through the bites of
infected mosquitoes. Furthermore, there are various other factors which are
supporting the growth of India malaria vaccine market such as growing
government initiatives, affordable vaccines, rising advancements in
biotechnology, and others.
Key Market Drivers
Rise in Occurrences of Malaria
The
high burden of malaria in India is one of the main drivers of the demand for
malaria vaccines. Malaria remains a significant public health issue in the
country, with millions of cases reported each year, particularly in rural and
underprivileged areas. Despite significant efforts to control the disease
through vector control, diagnosis, treatment, and health education, malaria
remains a major cause of morbidity and mortality in India. Therefore, there is
a surge in demand for the malaria vaccines in the country. The development of
an effective malaria vaccine has the potential to significantly reduce the
burden of malaria in India and other malaria-endemic countries. Thus, malaria
vaccine would provide a highly effective tool for preventing malaria infection,
particularly in high-risk populations, such as children under five and pregnant
women. It would also reduce the number of cases of severe malaria and the
associated morbidity and mortality. According to the World Health
Organization (WHO), India accounted for 3% of the global malaria burden in
2019, with an estimated 247 million cases of malaria.
Moreover,
the burden of malaria in India is particularly high in the states of Odisha,
Chhattisgarh, Jharkhand, and the northeast region of the country. These areas
are characterized by high rates of poverty, poor sanitation, and a lack of
access to healthcare, which contribute to the persistence of malaria.
Therefore, the rising prevalence of malaria is expected to bolster the growth
of the India malaria vaccine market in the upcoming years.
Increasing Government Support
Increasing
government support is one of the crucial factors for the growth of India's
malaria vaccine market. The Indian government has recognized the importance of
malaria prevention and control and has implemented several initiatives to
address the high burden of malaria in the country. The government has also
launched several awareness campaigns to promote the use of these malaria
prevention and control measures. In addition to these initiatives, the Indian
government has provided support for the development of malaria vaccines through
various research and development programs. For instance, in 2022, the
Ministry of Health and Family Welfare of India launched a campaign named Jan
Abhiyaans with log bhaagidari (people’s participation) to enthuse and engage
people and communities to ensure that their neighborhoods, premises, and homes
for vector control and elimination.
Furthermore,
the Indian government has also introduced policies to support the manufacturing
of vaccines within the country. The government's support for malaria vaccine
research, development, and manufacturing has helped to create a favorable
environment for the growth of India's malaria vaccine market. The government's
initiatives have helped to attract investment in malaria vaccine research and
development, and the policies supporting the manufacturing of vaccines within
the country have helped to create a competitive and vibrant vaccine
manufacturing industry in India.
Download Free Sample Report
Key Market Challenges
Regulatory and Approval
Challenges
One
of the major challenges facing the India malaria vaccine market is the complex
and time-consuming regulatory approval process. India has a large and diverse
population with varying levels of malaria transmission, and the regulatory
landscape must account for these factors when evaluating malaria vaccine
candidates. The rigorous testing and approval process for vaccines, especially
in the context of a disease like malaria, which has multiple strains and
geographical variations, complicates the development timeline. Additionally,
the lack of a streamlined and unified regulatory approach across states can
further delay vaccine distribution. India also faces challenges related to
public health infrastructure, which can affect the smooth execution of large-scale
clinical trials, data collection, and post-marketing surveillance. With the
demand for timely malaria vaccination programs, the delay in regulatory
approvals can hinder the ability to address public health concerns effectively.
Furthermore, variations in vaccine efficacy due to local conditions, such as
resistance to certain strains of malaria, pose additional challenges for
obtaining regulatory approval for vaccines that can be widely used across the
country.
Distribution and Accessibility
Issues
Another
significant challenge facing the malaria vaccine market in India is the
distribution and accessibility of the vaccine, especially in rural and remote
regions. Despite India’s progress in healthcare, a large portion of its
population still lives in areas where access to healthcare facilities is
limited, making it difficult to implement widespread vaccination campaigns. The
cold chain logistics required for storing and transporting vaccines, especially
in regions with inadequate infrastructure, further exacerbates the issue.
Moreover, the affordability of malaria vaccines is a critical concern, as many
rural populations may not have the financial means to access vaccines,
particularly in areas with high malaria burden. Government health initiatives and
collaborations with international organizations like the World Health
Organization (WHO) are crucial to overcoming these barriers, but challenges in
funding, distribution networks, and local health system capacities still
persist. Ensuring equitable access to malaria vaccines across all regions of
India remains a complex task that requires overcoming both logistical and
economic hurdles.
Key Market Trends
Growing Awareness About the
Importance of Malaria Treatment
Growing
awareness among people about the importance of malaria treatment is a
significant factor that can contribute to the growth of the India malaria
vaccine market. In recent years, there has been growing awareness among people
about the importance of malaria prevention, diagnosis, and treatment. This
growing awareness has been supported by government initiatives and public
health campaigns aimed at educating people about the disease and its prevention
and treatment. As more people become aware of the importance of malaria
prevention and treatment, there is a greater demand for effective tools for
malaria control, including vaccines. Also, the growing awareness among people
about the importance of malaria treatment and prevention is also creating a
favorable environment for investment in malaria vaccine research and
development. Investors and stakeholders are increasingly recognizing the
potential of the malaria vaccine market, and the growing demand for malaria
vaccines is likely to drive investment in this area. Furthermore, the growing
awareness about the importance of malaria treatment is also creating a demand
for affordable and effective malaria vaccines. This demand is particularly
significant in India, where access to healthcare is often limited in rural and
underprivileged areas. Affordable and effective malaria vaccines can help to
reduce the burden of malaria in these areas and improve access to healthcare
for vulnerable populations.
Growing Research &
Development Activities
Research
and development (R&D) are a crucial factor that can significantly
contribute to the growth of the India vaccine market. R&D plays a vital
role in the development of vaccines, including malaria vaccines. In recent
years, there has been a significant increase in R&D investment in India.
The Indian government has implemented several initiatives to promote R&D in
various sectors, including healthcare. For example, the Department of Science
and Technology has established several programs to support R&D in
biotechnology and healthcare. The increasing focus on R&D in India has
created a favorable environment for the development of vaccines, including
malaria vaccines. Several research institutions in India are working on the
development of malaria vaccines, and the investment in R&D is likely to
drive the growth of the India malaria vaccine market. Moreover, the
availability of a skilled workforce and the presence of world-class research
institutions in India have also contributed to the growth of the R&D sector.
This has facilitated the development of innovative technologies and solutions,
including vaccines. Moreover, researchers are working on various approaches to
develop malaria vaccines, including subunit vaccines, whole parasite vaccines,
and genetically attenuated parasite vaccines. Through this research, scientists
can gain a better understanding of the parasite's biology and the immune
responses required for protection, which can ultimately lead to the development
of effective malaria vaccines. Therefore, the increasing research &
development activities in the country is expected to support the growth of the
India malaria vaccine market in the forthcoming years.
Segmental Insights
Route of Administration Insights
Based
on the route of administration, the intramuscular category is currently
dominating the India malaria vaccine market due to several key advantages it
offers in terms of efficacy, ease of administration, and acceptance among
healthcare professionals. Intramuscular injections allow for better absorption
of vaccines compared to subcutaneous or oral routes, which is crucial for
ensuring a robust immune response, especially for complex vaccines like those
targeting malaria. In addition, the intramuscular route is familiar to
healthcare providers across India, making it easier to implement at scale. IM
injections are also widely used in existing vaccination programs, providing a
sense of standardization that helps ensure smooth integration into national
immunization efforts. As malaria vaccination campaigns continue to expand, the
familiarity and simplicity of administering vaccines via the IM route are
expected to play a pivotal role in encouraging adoption by healthcare
professionals and the public. Furthermore, the consistent success of other
vaccines delivered intramuscularly in India helps maintain trust in the safety
and effectiveness of this administration method for malaria vaccines.
Download Free Sample Report
Regional Insights
Based
on the region, East India was dominating in India Vaccine Market in 2024. East
India, comprising states like West Bengal, Odisha, Bihar, and Assam, is
experiencing a significant malaria burden, making it a key region for the
malaria vaccine market. These states are known for having high transmission
rates of malaria, with large populations living in areas prone to endemic
transmission. The prevalence of malaria in these regions, particularly among
vulnerable populations such as children and pregnant women, has made it a
priority for both government and public health organizations to implement
effective prevention strategies, including vaccination. The demand for malaria
vaccines is therefore high in East India, where targeted interventions are
necessary to control and reduce malaria incidence. The geographical factors and
environmental conditions in these states, such as monsoons and high humidity,
create ideal breeding grounds for malaria-carrying mosquitoes, exacerbating the
disease burden and increasing the urgency of vaccination programs.
Consequently, East India’s substantial malaria cases have made it the dominant
market for malaria vaccines in the country, driving efforts to prioritize
vaccine distribution and ensure timely access.
Recent Developments
- In
May 2024, Serum Institute of India, the world’s largest manufacturer of
vaccines by number of doses, marks a significant milestone with the shipment of
its first set of R21/Matrix-M™ malaria vaccine to Africa. The initial shipment
will be sent to the Central African Republic (CAR), followed by other African
countries such as South Sudan and Democratic Republic of Congo in the next
coming days. In total, 1,63,800 doses of the R21/Matrix-M™ malaria vaccine have
been specifically allocated for CAR region, out of which only 43,200 doses will
be dispatched today from Serum Institute of India’s facility.
- In
June 2023, the India Health Fund (IHF), which is a funding initiative by Tata
Trusts, has announced its support for the two platform tools developed by
Ameliorate Biotech Pvt Ltd and Medprime Technologies, the tools are a fever
panel to detect chikungunya, dengue, malaria and microscope-agnostic AI-enabled
diagnosis software that is applicable across diseases.
Key Market Players
- Gennova
Biopharmaceuticals Ltd
- Zydus Group
- Serum Institute of India Private Limited
- Bharat Biotech International Limited
- Indian Immunologicals Limited, Inc.
- Panacea Biotec
- Mynvax
- Cadila Pharmaceuticals
- Biological E Limited
- Sanofi Pasteurs Health
|
By Vaccine Type
|
By Route of Administration
|
By Region
|
- Pre-Erythrocytic
- Erythrocytic
- Multi-antigen
- Others
|
- Intramuscular
- Subcutaneous
- Intradermal
- Others
|
- North
India
- South
India
- East
India
- West
India
|
Report Scope:
In this report, India Malaria
Vaccine Market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
India Malaria Vaccine Market, By Vaccine Type:
o
Pre-Erythrocytic
o
Erythrocytic
o
Multi-antigen
o
Others
·
India
Malaria Vaccine Market, By Route of Administration:
o
Intramuscular
o
Subcutaneous
o
Intradermal
o
Others
·
India Malaria Vaccine Market, By Region:
o
North
India
o
South
India
o
East
India
o
West
India
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present India Malaria Vaccine Market
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
India Malaria Vaccine Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at sales@techsciresearch.com